- Home
- PENN vs ARWR Comparison
PENN vs ARWR Comparison
Compare PENN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENN
- ARWR
- Stock Information
- Founded
- PENN 1972
- ARWR 2003
- Country
- PENN United States
- ARWR United States
- Employees
- PENN N/A
- ARWR N/A
- Industry
- PENN Hotels/Resorts
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- PENN Consumer Discretionary
- ARWR Health Care
- Exchange
- PENN Nasdaq
- ARWR Nasdaq
- Market Cap
- PENN 2.8B
- ARWR 2.5B
- IPO Year
- PENN 1994
- ARWR 1993
- Fundamental
- Price
- PENN $19.62
- ARWR $30.24
- Analyst Decision
- PENN Buy
- ARWR Strong Buy
- Analyst Count
- PENN 19
- ARWR 8
- Target Price
- PENN $22.89
- ARWR $47.75
- AVG Volume (30 Days)
- PENN 3.3M
- ARWR 3.1M
- Earning Date
- PENN 11-06-2025
- ARWR 08-07-2025
- Dividend Yield
- PENN N/A
- ARWR N/A
- EPS Growth
- PENN N/A
- ARWR N/A
- EPS
- PENN N/A
- ARWR N/A
- Revenue
- PENN $6,745,700,000.00
- ARWR $572,976,000.00
- Revenue This Year
- PENN $8.25
- ARWR $22,306.37
- Revenue Next Year
- PENN $5.49
- ARWR N/A
- P/E Ratio
- PENN N/A
- ARWR N/A
- Revenue Growth
- PENN 7.33
- ARWR 2816.20
- 52 Week Low
- PENN $13.25
- ARWR $9.57
- 52 Week High
- PENN $23.08
- ARWR $29.80
- Technical
- Relative Strength Index (RSI)
- PENN 54.10
- ARWR 77.85
- Support Level
- PENN $19.60
- ARWR $27.10
- Resistance Level
- PENN $20.61
- ARWR $29.34
- Average True Range (ATR)
- PENN 0.53
- ARWR 1.47
- MACD
- PENN -0.05
- ARWR 0.50
- Stochastic Oscillator
- PENN 20.31
- ARWR 91.29
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.